| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.863 | 0.004 | 0.863 | Platelet aggregation inhibitor | 0.845 0.004 DBMET01849 0.827 0.004 DBMET01850 0.851 0.004 DBMET01851 | ||
| 0.844 | 0.003 | 0.844 | Platelet growth factor antagonist | 0.802 0.003 DBMET01849 0.744 0.003 DBMET01850 0.822 0.003 DBMET01851 | ||
| 0.793 | 0.003 | 0.793 | Platelet activating factor beta antagonist | 0.746 0.004 DBMET01849 0.698 0.004 DBMET01850 0.762 0.004 DBMET01851 | ||
| 0.736 | 0.007 | 0.737 | Angiogenesis inhibitor | 0.716 0.008 DBMET01849 0.645 0.013 DBMET01850 0.737 0.007 DBMET01851 | DBMET01851 | |
| 0.698 | 0.004 | 0.698 | Platelet activating factor antagonist | 0.647 0.004 DBMET01849 0.583 0.004 DBMET01850 0.671 0.004 DBMET01851 | ||
| 0.697 | 0.005 | 0.697 | Vascular endothelial growth factor antagonist | 0.623 0.005 DBMET01849 0.527 0.007 DBMET01850 0.655 0.005 DBMET01851 | ||
| 0.641 | 0.005 | 0.641 | Vascular endothelial growth factor 2 antagonist | 0.567 0.005 DBMET01849 0.467 0.009 DBMET01850 0.599 0.005 DBMET01851 | ||
| 0.631 | 0.004 | 0.637 | Calcium channel L-type activator | 0.624 0.004 DBMET01849 0.61 0.005 DBMET01850 0.637 0.004 DBMET01851 | DBMET01851 | |
| 0.513 | 0.004 | 0.513 | Fibroblast growth factor 1 antagonist | 0.442 0.004 DBMET01849 0.347 0.005 DBMET01850 0.439 0.004 DBMET01851 | ||
| 0.466 | 0.008 | 0.466 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.44 0.011 DBMET01849 0.399 0.017 DBMET01850 0.442 0.011 DBMET01851 | ||
| 0.459 | 0.01 | 0.459 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.419 0.013 DBMET01849 0.362 0.021 DBMET01850 0.425 0.013 DBMET01851 | ||
| 0.427 | 0.004 | 0.427 | Death-associated protein kinase 2 inhibitor | 0.404 0.004 DBMET01849 0.359 0.005 DBMET01850 0.394 0.004 DBMET01851 | ||
| 0.434 | 0.012 | 0.434 | Death-associated protein kinase 3 inhibitor | 0.401 0.017 DBMET01849 0.372 0.022 DBMET01850 0.395 0.018 DBMET01851 | ||
| 0.428 | 0.01 | 0.428 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.408 0.013 DBMET01849 0.373 0.02 DBMET01850 0.399 0.014 DBMET01851 | ||
| 0.419 | 0.004 | 0.419 | Focal adhesion kinase 2 inhibitor | 0.367 0.005 DBMET01849 0.323 0.01 DBMET01850 0.377 0.005 DBMET01851 | ||
| 0.396 | 0.01 | 0.396 | Vascular endothelial growth factor 3 antagonist | 0.362 0.013 DBMET01849 0.297 0.019 DBMET01850 0.396 0.01 DBMET01851 | ||
| 0.405 | 0.02 | 0.405 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.374 0.028 DBMET01849 0.361 0.032 DBMET01850 0.389 0.024 DBMET01851 | ||
| 0.38 | 0.004 | 0.38 | Ferrochelatase inhibitor | 0.239 0.015 DBMET01849 0.244 0.014 DBMET01850 0.234 0.016 DBMET01851 | ||
| 0.37 | 0.021 | 0.401 | Cyclic AMP phosphodiesterase inhibitor | 0.401 0.016 DBMET01849 0.312 0.037 DBMET01850 0.359 0.024 DBMET01851 | DBMET01849 | |
| 0.365 | 0.017 | 0.365 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.345 0.021 DBMET01849 0.263 0.039 DBMET01850 0.357 0.019 DBMET01851 | ||
| 0.349 | 0.003 | 0.349 | Biliverdin reductase inhibitor | 0.269 0.004 DBMET01849 0.269 0.004 DBMET01850 0.269 0.004 DBMET01851 | ||
| 0.349 | 0.005 | 0.377 | Platelet activating factor alpha antagonist | 0.342 0.005 DBMET01849 0.272 0.009 DBMET01850 0.377 0.005 DBMET01851 | DBMET01851 | |
| 0.352 | 0.01 | 0.375 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.375 0.009 DBMET01849 0.292 0.019 DBMET01850 0.359 0.01 DBMET01851 | DBMET01849 | |
| 0.329 | 0.017 | 0.333 | RET inhibitor | 0.315 0.019 DBMET01849 0.267 0.028 DBMET01850 0.333 0.017 DBMET01851 | DBMET01851 | |
| 0.324 | 0.02 | 0.324 | TRKC antagonist | 0.301 0.027 DBMET01849 0.261 0.044 DBMET01850 0.303 0.026 DBMET01851 | ||
| 0.296 | 0.011 | 0.296 | Vascular endothelial growth factor 1 antagonist | 0.243 0.018 DBMET01849 0.201 0.026 DBMET01850 0.256 0.015 DBMET01851 | ||
| 0.296 | 0.012 | 0.316 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.27 0.014 DBMET01849 0.186 0.025 DBMET01850 0.316 0.01 DBMET01851 | DBMET01851 | |
| 0.279 | 0.005 | 0.279 | Polo-like kinase-4 inhibitor | 0.257 0.007 DBMET01849 0.222 0.011 DBMET01850 0.255 0.007 DBMET01851 | ||
| 0.273 | 0.007 | 0.273 | Aurora-C kinase inhibitor | 0.251 0.009 DBMET01849 0.23 0.013 DBMET01850 0.252 0.009 DBMET01851 | ||
| 0.268 | 0.026 | 0.268 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.22 0.04 DBMET01849 0.152 0.064 DBMET01850 0.221 0.04 DBMET01851 | ||
| 0.338 | 0.105 | 0.397 | Histamine release inhibitor | 0.397 0.077 DBMET01849 0.264 0.145 DBMET01850 0.359 0.095 DBMET01851 | DBMET01849 | |
| 0.291 | 0.064 | 0.291 | Insulysin inhibitor | 0.291 0.064 DBMET01849 0.235 0.111 DBMET01850 0.275 0.076 DBMET01851 | ||
| 0.274 | 0.048 | 0.302 | Tyrosine 3 hydroxylase inhibitor | 0.302 0.032 DBMET01849 0.253 0.065 DBMET01850 0.3 0.033 DBMET01851 | DBMET01849 | |
| 0.251 | 0.026 | 0.251 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.212 0.034 DBMET01849 0.169 0.046 DBMET01850 0.234 0.029 DBMET01851 | ||
| 0.242 | 0.025 | 0.268 | Phospholipase A2 inhibitor | 0.268 0.019 DBMET01849 0.228 0.03 DBMET01850 0.251 0.023 DBMET01851 | DBMET01849 | |
| 0.304 | 0.095 | 0.355 | Vasodilator, peripheral | 0.292 0.101 DBMET01849 0.355 0.071 DBMET01850 0.272 0.112 DBMET01851 | DBMET01850 | |
| 0.233 | 0.024 | 0.233 | Protein kinase (CK1) gamma 2 inhibitor | 0.187 0.036 DBMET01849 0.148 0.05 DBMET01850 0.18 0.038 DBMET01851 | ||
| 0.297 | 0.09 | 0.302 | Antithrombotic | 0.302 0.087 DBMET01849 0.24 0.134 DBMET01850 0.273 0.108 DBMET01851 | DBMET01849 | |
| 0.255 | 0.051 | 0.255 | MAP kinase kinase 2 inhibitor | 0.246 0.056 DBMET01849 0.195 0.085 DBMET01850 0.249 0.054 DBMET01851 | ||
| 0.291 | 0.088 | 0.331 | Sodium/bile acid cotransporter inhibitor | 0.331 0.053 DBMET01849 0.313 0.067 DBMET01850 0.32 0.062 DBMET01851 | DBMET01849 | |
| 0.192 | 0.003 | 0.192 | NMDA receptor glycine site antagonist | 0.152 0.003 DBMET01849 0.088 0.004 DBMET01850 0.142 0.003 DBMET01851 | ||
| 0.225 | 0.036 | 0.225 | Protein kinase (CK1) gamma inhibitor | 0.179 0.053 DBMET01849 0.14 0.074 DBMET01850 0.173 0.055 DBMET01851 | ||
| 0.257 | 0.069 | 0.257 | Platelet antagonist | 0.229 0.082 DBMET01849 0.23 0.082 DBMET01850 0.221 0.087 DBMET01851 | ||
| 0.271 | 0.088 | 0.288 | Immunostimulant | 0.288 0.082 DBMET01849 0.259 0.092 DBMET01850 0.281 0.084 DBMET01851 | DBMET01849 | |
| 0.193 | 0.023 | 0.193 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.183 0.03 DBMET01849 0.167 0.046 DBMET01850 0.188 0.026 DBMET01851 | ||
| 0.182 | 0.015 | 0.263 | Porphobilinogen synthase inhibitor | 0.171 0.016 DBMET01849 0.263 0.007 DBMET01850 0.179 0.015 DBMET01851 | DBMET01850 | |
| 0.231 | 0.067 | 0.233 | EphB2 antagonist | 0.227 0.07 DBMET01849 0.164 0.117 DBMET01850 0.233 0.067 DBMET01851 | DBMET01851 | |
| 0.197 | 0.036 | 0.232 | Neurotensin receptor agonist | 0.229 0.025 DBMET01849 0.183 0.046 DBMET01850 0.232 0.024 DBMET01851 | DBMET01851 | |
| 0.199 | 0.047 | 0.199 | Protein kinase (CK1) gamma 3 inhibitor | 0.182 0.059 DBMET01849 0.157 0.082 DBMET01850 0.176 0.064 DBMET01851 | ||
| 0.199 | 0.048 | 0.199 | Protein kinase C nu inhibitor | 0.17 0.06 DBMET01849 0.132 0.081 DBMET01850 0.169 0.06 DBMET01851 | ||
| 0.216 | 0.068 | 0.216 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.185 0.084 DBMET01849 0.138 0.125 DBMET01850 0.185 0.085 DBMET01851 | ||
| 0.205 | 0.058 | 0.206 | Growth factor agonist | 0.2 0.063 DBMET01849 0.169 0.104 DBMET01850 0.206 0.058 DBMET01851 | DBMET01851 | |
| 0.147 | 0.008 | 0.147 | Glycine receptor antagonist | 0.118 0.019 DBMET01849 0.098 0.034 DBMET01850 0.118 0.019 DBMET01851 | ||
| 0.195 | 0.065 | 0.195 | LIM domain kinase 1 inhibitor | 0.165 0.084 DBMET01849 0.141 0.107 DBMET01850 0.166 0.083 DBMET01851 | ||
| 0.173 | 0.044 | 0.19 | c-Src kinase inhibitor | 0.182 0.041 DBMET01849 0.147 0.057 DBMET01850 0.19 0.038 DBMET01851 | DBMET01851 | |
| 0.231 | 0.103 | 0.231 | Gastrin inhibitor | |||
| 0.155 | 0.028 | 0.173 | TRPA1 agonist | 0.173 0.019 DBMET01849 0.148 0.033 DBMET01850 0.151 0.03 DBMET01851 | DBMET01849 | |
| 0.294 | 0.168 | 0.304 | Cyclophilin D inhibitor | 0.299 0.164 DBMET01849 0.29 0.172 DBMET01850 0.304 0.159 DBMET01851 | DBMET01851 | |
| 0.144 | 0.035 | 0.144 | Photosensitizer | 0.135 0.042 DBMET01849 0.11 0.07 DBMET01850 0.144 0.035 DBMET01851 | ||
| 0.12 | 0.013 | 0.12 | NMDA receptor agonist | 0.083 0.027 DBMET01849 0.069 0.037 DBMET01850 0.084 0.026 DBMET01851 | ||
| 0.174 | 0.069 | 0.182 | Src kinase inhibitor | 0.176 0.067 DBMET01849 0.14 0.091 DBMET01850 0.182 0.064 DBMET01851 | DBMET01851 | |
| 0.25 | 0.147 | 0.254 | Calcium channel activator | 0.227 0.175 DBMET01849 0.254 0.143 DBMET01851 | DBMET01851 | |
| 0.283 | 0.185 | 0.293 | 5 Hydroxytryptamine release inhibitor | 0.293 0.173 DBMET01849 0.266 0.206 DBMET01851 | DBMET01849 | |
| 0.173 | 0.078 | 0.176 | Lipocortins synthesis antagonist | 0.176 0.074 DBMET01849 0.144 0.115 DBMET01850 0.153 0.1 DBMET01851 | DBMET01849 | |
| 0.232 | 0.14 | 0.248 | Interleukin 2 agonist | 0.248 0.12 DBMET01849 0.234 0.137 DBMET01850 0.242 0.128 DBMET01851 | DBMET01849 | |
| 0.197 | 0.107 | 0.219 | Vasodilator | 0.219 0.09 DBMET01849 0.212 0.095 DBMET01850 0.216 0.092 DBMET01851 | DBMET01849 | |
| 0.101 | 0.016 | 0.101 | NMDA receptor glycine site agonist | 0.068 0.038 DBMET01849 0.059 0.046 DBMET01850 0.069 0.037 DBMET01851 | ||
| 0.162 | 0.078 | 0.165 | Growth hormone agonist | 0.165 0.076 DBMET01849 0.148 0.089 DBMET01850 0.165 0.076 DBMET01851 | DBMET01851 | |
| 0.109 | 0.026 | 0.109 | HIV-1 reverse transcriptase inhibitor | 0.097 0.032 DBMET01849 0.092 0.035 DBMET01850 0.094 0.034 DBMET01851 | ||
| 0.274 | 0.191 | 0.351 | Apoptosis agonist | 0.351 0.138 DBMET01849 0.317 0.161 DBMET01850 0.349 0.139 DBMET01851 | DBMET01849 | |
| 0.123 | 0.041 | 0.123 | Adenylate kinase inhibitor | 0.098 0.071 DBMET01849 0.093 0.08 DBMET01850 0.098 0.07 DBMET01851 | ||
| 0.186 | 0.107 | 0.232 | ErbB-1 antagonist | 0.209 0.08 DBMET01849 0.164 0.145 DBMET01850 0.232 0.062 DBMET01851 | DBMET01851 | |
| 0.194 | 0.118 | 0.239 | Hypoglycemic | 0.238 0.084 DBMET01849 0.191 0.121 DBMET01850 0.239 0.083 DBMET01851 | DBMET01851 | |
| 0.114 | 0.039 | 0.153 | NMDA receptor antagonist | 0.15 0.024 DBMET01849 0.103 0.045 DBMET01850 0.153 0.024 DBMET01851 | DBMET01851 | |
| 0.087 | 0.013 | 0.087 | MDM2 inhibitor | 0.065 0.055 DBMET01849 0.067 0.048 DBMET01850 0.067 0.047 DBMET01851 | ||
| 0.106 | 0.033 | 0.122 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.113 0.029 DBMET01849 0.122 0.024 DBMET01850 0.113 0.029 DBMET01851 | DBMET01850 | |
| 0.137 | 0.064 | 0.137 | Death-associated protein kinase 1 inhibitor | 0.123 0.101 DBMET01849 0.123 0.101 DBMET01851 | ||
| 0.097 | 0.029 | 0.097 | Polo-like kinase-2 inhibitor | 0.082 0.042 DBMET01849 0.064 0.059 DBMET01850 0.086 0.039 DBMET01851 | ||
| 0.094 | 0.028 | 0.131 | Phenylalanine 4-hydroxylase inhibitor | 0.104 0.024 DBMET01849 0.131 0.015 DBMET01850 0.111 0.021 DBMET01851 | DBMET01850 | |
| 0.117 | 0.052 | 0.117 | GABA C receptor agonist | 0.092 0.076 DBMET01849 0.092 0.076 DBMET01850 0.092 0.076 DBMET01851 | ||
| 0.147 | 0.084 | 0.154 | Thrombolytic | 0.154 0.078 DBMET01849 0.126 0.103 DBMET01850 0.143 0.087 DBMET01851 | DBMET01849 | |
| 0.219 | 0.157 | 0.252 | Apoptosis antagonist | 0.252 0.126 DBMET01849 0.231 0.147 DBMET01850 0.25 0.128 DBMET01851 | DBMET01849 | |
| 0.109 | 0.047 | 0.109 | DNA directed RNA polymerase inhibitor | 0.096 0.061 DBMET01849 0.088 0.073 DBMET01850 0.093 0.066 DBMET01851 | ||
| 0.148 | 0.091 | 0.17 | Mcl-1 antagonist | 0.17 0.073 DBMET01849 0.164 0.077 DBMET01850 0.168 0.075 DBMET01851 | DBMET01849 | |
| 0.171 | 0.122 | 0.281 | Free radical scavenger | 0.281 0.057 DBMET01849 0.254 0.067 DBMET01850 0.263 0.063 DBMET01851 | DBMET01849 | |
| 0.138 | 0.092 | 0.164 | Protein-tyrosine phosphatase inhibitor | 0.155 0.074 DBMET01849 0.164 0.066 DBMET01850 0.153 0.075 DBMET01851 | DBMET01850 | |
| 0.107 | 0.064 | 0.111 | CDC-like kinase 3 inhibitor | 0.103 0.073 DBMET01849 0.111 0.056 DBMET01850 0.106 0.067 DBMET01851 | DBMET01850 | |
| 0.064 | 0.022 | 0.073 | Plasminogen activator inhibitor antagonist | 0.071 0.018 DBMET01849 0.073 0.017 DBMET01850 0.063 0.022 DBMET01851 | DBMET01850 | |
| 0.107 | 0.066 | 0.114 | Multidrug resistance-associated protein 1 inhibitor | 0.114 0.055 DBMET01849 0.106 0.068 DBMET01851 | DBMET01849 | |
| 0.071 | 0.032 | 0.071 | Prostaglandin EP2 antagonist | 0.065 0.036 DBMET01849 0.055 0.046 DBMET01850 0.066 0.036 DBMET01851 | ||
| 0.103 | 0.063 | 0.103 | Factor V inhibitor | 0.094 0.084 DBMET01849 0.095 0.083 DBMET01850 0.092 0.091 DBMET01851 | ||
| 0.124 | 0.086 | 0.124 | Histone deacetylase SIRT1 inhibitor | 0.124 0.086 DBMET01849 0.115 0.098 DBMET01850 0.121 0.09 DBMET01851 | ||
| 0.116 | 0.079 | 0.116 | Glutamate receptor antagonist | 0.11 0.085 DBMET01849 0.108 0.088 DBMET01851 | ||
| 0.12 | 0.083 | 0.163 | NADPH oxidase inhibitor | 0.163 0.047 DBMET01849 0.13 0.072 DBMET01850 0.149 0.055 DBMET01851 | DBMET01849 | |
| 0.175 | 0.142 | 0.189 | RNA-directed DNA polymerase inhibitor | 0.182 0.128 DBMET01849 0.189 0.116 DBMET01851 | DBMET01851 | |
| 0.136 | 0.104 | 0.136 | CDC-like kinase 2 inhibitor | |||
| 0.058 | 0.028 | 0.058 | Sphingosine 1-phosphate receptor 5 agonist | 0.053 0.038 DBMET01849 0.051 0.044 DBMET01850 0.051 0.043 DBMET01851 | ||
| 0.084 | 0.055 | 0.096 | Glutathione S-transferase inhibitor | 0.079 0.062 DBMET01849 0.096 0.041 DBMET01850 0.086 0.052 DBMET01851 | DBMET01850 | |
| 0.105 | 0.076 | 0.105 | Interleukin 2 antagonist | 0.099 0.096 DBMET01851 | ||
| 0.115 | 0.09 | 0.145 | Bone formation stimulant | 0.138 0.069 DBMET01849 0.108 0.097 DBMET01850 0.145 0.063 DBMET01851 | DBMET01851 | |
| 0.214 | 0.191 | 0.262 | GABA C receptor rho-3 antagonist | 0.21 0.195 DBMET01849 0.262 0.144 DBMET01851 | DBMET01851 | |
| 0.102 | 0.08 | 0.102 | Aurora-B kinase inhibitor | 0.093 0.092 DBMET01851 | ||
| 0.1 | 0.078 | 0.122 | Protein-tyrosine phosphatase 1B inhibitor | 0.122 0.062 DBMET01849 0.118 0.065 DBMET01850 0.115 0.067 DBMET01851 | DBMET01849 | |
| 0.086 | 0.066 | 0.086 | Triose-phosphate isomerase inhibitor | |||
| 0.055 | 0.037 | 0.055 | Thromboxane synthase inhibitor | |||
| 0.087 | 0.069 | 0.087 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.049 | 0.032 | 0.049 | Mineralocorticoid receptor antagonist | 0.047 0.035 DBMET01849 0.043 0.042 DBMET01851 | ||
| 0.08 | 0.065 | 0.08 | T cell inhibitor | |||
| 0.129 | 0.116 | 0.129 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.035 | 0.022 | 0.035 | Free fatty acid receptor 1 antagonist | |||
| 0.072 | 0.061 | 0.076 | GABA B receptor agonist | 0.076 0.05 DBMET01849 0.076 0.051 DBMET01851 | DBMET01851 | |
| 0.09 | 0.082 | 0.114 | Mediator release inhibitor | 0.101 0.069 DBMET01849 0.114 0.054 DBMET01850 0.111 0.057 DBMET01851 | DBMET01850 | |
| 0.161 | 0.152 | 0.261 | Antioxidant | 0.261 0.078 DBMET01849 0.242 0.088 DBMET01850 0.248 0.085 DBMET01851 | DBMET01849 | |
| 0.034 | 0.026 | 0.034 | Kainate receptor 2 antagonist | |||
| 0.135 | 0.13 | 0.188 | Pyruvate kinase inhibitor | 0.188 0.088 DBMET01849 0.178 0.095 DBMET01851 | DBMET01849 | |
| 0.139 | 0.134 | 0.141 | Succinate dehydrogenase inhibitor | 0.141 0.13 DBMET01849 0.141 0.131 DBMET01850 | DBMET01850 | |
| 0.061 | 0.056 | 0.071 | Check point kinase 1 inhibitor | 0.071 0.045 DBMET01849 0.069 0.047 DBMET01851 | DBMET01849 | |
| 0.067 | 0.062 | 0.067 | Glycine receptor agonist | |||
| 0.02 | 0.016 | 0.02 | Histone-lysine N-methyltransferase EZH2 inhibitor | |||
| 0.108 | 0.105 | 0.119 | Growth factor antagonist | 0.119 0.093 DBMET01851 | DBMET01851 | |
| 0.027 | 0.024 | 0.027 | Prostaglandin EP3 antagonist | |||
| 0.086 | 0.083 | 0.099 | Bile acid receptor antagonist | 0.099 0.052 DBMET01849 0.093 0.065 DBMET01851 | DBMET01849 | |
| 0.016 | 0.014 | 0.016 | Free fatty acid receptor 1 agonist | |||
| 0.062 | 0.06 | 0.062 | Prostaglandin-E synthase inhibitor | |||
| 0.043 | 0.041 | 0.043 | Aldosterone antagonist | |||
| 0.06 | 0.059 | 0.062 | Sirtuin 1 inhibitor | 0.062 0.056 DBMET01849 | DBMET01849 | |
| 0.143 | 0.143 | 0.192 | Dyrk kinase inhibitor | 0.181 0.11 DBMET01849 0.17 0.118 DBMET01850 0.192 0.103 DBMET01851 | DBMET01851 | |
| 0.03 | 0.033 | 0.034 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.031 0.029 DBMET01849 0.034 0.023 DBMET01850 | DBMET01850 | |
| 0.064 | 0.067 | 0.071 | CDC25A inhibitor | 0.068 0.061 DBMET01849 0.071 0.055 DBMET01850 0.071 0.056 DBMET01851 | DBMET01851 | |
| 0.022 | 0.029 | 0.036 | Thyroid hormone agonist | 0.036 0.008 DBMET01849 0.027 0.016 DBMET01850 0.03 0.012 DBMET01851 | DBMET01849 | |
| 0.055 | 0.064 | 0.085 | Beta adrenoreceptor antagonist | 0.069 0.04 DBMET01849 0.085 0.024 DBMET01850 0.066 0.044 DBMET01851 | DBMET01850 | |
| 0.122 | 0.134 | 0.17 | Dual specificity phosphatase inhibitor | 0.137 0.11 DBMET01849 0.17 0.075 DBMET01850 0.138 0.109 DBMET01851 | DBMET01850 | |
| 0.101 | 0.115 | 0.175 | Lipid peroxidase inhibitor | 0.169 0.056 DBMET01849 0.175 0.053 DBMET01850 0.161 0.061 DBMET01851 | DBMET01850 | |
| 0.178 | 0.191 | 0.222 | Thioredoxin glutathione reductase inhibitor | 0.222 0.154 DBMET01850 | DBMET01850 | |
| 0.124 | 0.139 | 0.171 | DNA methyltransferase I inhibitor | 0.16 0.094 DBMET01849 0.171 0.086 DBMET01851 | DBMET01851 | |
| 0.061 | 0.076 | 0.068 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.068 0.062 DBMET01849 | DBMET01849 | |
| 0.158 | 0.174 | 0.175 | Peptidyltransferase inhibitor | 0.172 0.144 DBMET01849 0.169 0.149 DBMET01850 0.175 0.138 DBMET01851 | DBMET01851 | |
| 0.116 | 0.135 | 0.137 | Adenylate cyclase stimulant | 0.137 0.088 DBMET01849 0.125 0.113 DBMET01851 | DBMET01849 | |
| 0.004 | 0.025 | 0.008 | Thyroid hormone beta agonist | 0.008 0.007 DBMET01849 | DBMET01849 | |
| 0.1 | 0.123 | 0.113 | CDC-like kinase 1 inhibitor | 0.113 0.102 DBMET01851 | DBMET01851 | |
| 0.088 | 0.117 | 0.108 | Epidermal growth factor receptor kinase inhibitor | 0.108 0.086 DBMET01851 | DBMET01851 | |
| 0.07 | 0.1 | 0.092 | Alcohol dehydrogenase inhibitor | 0.092 0.061 DBMET01849 0.087 0.069 DBMET01851 | DBMET01849 | |
| 0.127 | 0.159 | 0.174 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.164 0.119 DBMET01849 0.157 0.125 DBMET01850 0.174 0.11 DBMET01851 | DBMET01851 | |
| 0.124 | 0.157 | 0.137 | Heat shock protein 70 antagonist | 0.13 0.122 DBMET01849 0.137 0.087 DBMET01850 | DBMET01850 | |
| 0.068 | 0.105 | 0.082 | Prolactin inhibitor | 0.082 0.078 DBMET01849 | DBMET01849 | |
| 0.077 | 0.119 | 0.137 | DNA polymerase I inhibitor | 0.107 0.079 DBMET01849 0.137 0.056 DBMET01850 0.107 0.079 DBMET01851 | DBMET01850 | |
| 0.186 | 0.229 | 0.285 | 15-Lipoxygenase inhibitor | 0.285 0.141 DBMET01849 0.272 0.148 DBMET01850 0.239 0.173 DBMET01851 | DBMET01849 | |
| 0.111 | 0.157 | 0.149 | Melanin inhibitor | 0.149 0.082 DBMET01849 0.141 0.095 DBMET01851 | DBMET01849 | |
| 0.074 | 0.12 | 0.098 | Interleukin 12 antagonist | 0.089 0.074 DBMET01849 0.098 0.057 DBMET01851 | DBMET01851 | |
| 0.103 | 0.156 | 0.132 | Dual specificity phosphatase 3 inhibitor | 0.132 0.114 DBMET01850 | DBMET01850 | |
| 0.115 | 0.171 | 0.153 | Antimitotic | 0.144 0.127 DBMET01849 0.153 0.119 DBMET01851 | DBMET01851 | |
| 0.11 | 0.169 | 0.156 | Interleukin antagonist | 0.146 0.121 DBMET01849 0.156 0.114 DBMET01851 | DBMET01851 | |
| 0.077 | 0.138 | 0.111 | DOPA decarboxylase inhibitor | 0.111 0.057 DBMET01849 0.103 0.069 DBMET01851 | DBMET01849 | |
| 0.109 | 0.173 | 0.15 | DNA methylase inhibitor | 0.14 0.127 DBMET01849 0.15 0.117 DBMET01851 | DBMET01851 | |
| 0.097 | 0.164 | 0.127 | Farnesoid X receptor antagonist | 0.127 0.089 DBMET01849 0.12 0.103 DBMET01851 | DBMET01849 | |
| 0.098 | 0.165 | 0.115 | Papain-like protease (SARS coronavirus) inhibitor | 0.113 0.103 DBMET01849 0.115 0.097 DBMET01851 | DBMET01851 | |
| 0.142 | 0.24 | 0.173 | Nitric-oxide synthase stimulant | 0.173 0.144 DBMET01849 | DBMET01849 | |
| 0.073 | 0.193 | 0.119 | Peroxidase inhibitor | 0.119 0.101 DBMET01849 | DBMET01849 | |
| 0.04 | 0.16 | 0.092 | Monophenol monooxygenase inhibitor | 0.092 0.082 DBMET01849 | DBMET01849 | |
| 0.122 | 0.244 | 0.201 | Lipoxygenase inhibitor | 0.192 0.148 DBMET01849 0.201 0.139 DBMET01850 | DBMET01850 | |
| 0.13 | 0.253 | 0.217 | Transcription factor NF kappa B inhibitor | 0.217 0.153 DBMET01849 0.208 0.162 DBMET01851 | DBMET01849 | |
| 0.053 | 0.177 | 0.09 | Cystathionine beta-synthase inhibitor | 0.09 0.089 DBMET01849 | DBMET01849 | |
| 0.026 | 0.345 | 0.105 | Bronchodilator | 0.105 0.058 DBMET01850 | DBMET01850 | |
| 0.031 | 0.446 | 0.105 | Estrogen antagonist | 0.105 0.087 DBMET01849 0.104 0.088 DBMET01851 | DBMET01849 | |
| 0.021 | 0.454 | 0.092 | Estrogen receptor beta antagonist | 0.091 0.082 DBMET01849 0.092 0.079 DBMET01851 | DBMET01851 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |